Hyliion (HYLN) Q2 2025: Commercial Launch Pushed to 2026 as $1B Saudi MOU and 30% Tax Credit Reshape Trajectory

Hyliion’s Q2 marked a pivotal shift, with commercialization of its Carno Power Module delayed to 2026 as technical hurdles were cleared and major policy and partnership catalysts emerged. The newly enacted 30% investment tax credit and a $1 billion MOU in Saudi Arabia reinforce the long-term opportunity, but near-term revenue will remain research-driven as the company focuses on delivering all early adopter units this year. Investors should focus on Hyliion’s ability to convert military and commercial pilots into scalable demand as product validation unfolds.

Summary

  • Commercialization Timeline Reset: Carno Power Module full launch now targeted for 2026 to allow for field validation and customer feedback integration.
  • Manufacturing and Technical Milestones: In-house LEM production and regen redesign resolve key bottlenecks, enabling resumed deliveries and improved system performance.
  • Policy and Partnership Tailwinds: 30% investment tax credit and $1B Saudi MOU expand addressable market and validate strategic direction.

Performance Analysis

Hyliion’s Q2 results reflect a company in transition, with revenue of $1.5 million solely from research and development (R&D) services tied to U.S. Navy contracts. Gross profit was positive but modest, as the company remains pre-commercial with its Carno Power Module, a fuel-agnostic linear generator targeting distributed clean power. Operating expenses rose to $15.8 million, driven by a ramp in R&D as Hyliion scaled additive manufacturing and tackled technical bottlenecks in core components.

Cash burn slowed significantly, with $13.5 million used in Q2 versus $20.9 million in Q1, reflecting lower capital spending and a focus on operational discipline. The balance sheet remains robust, ending the quarter with $185.3 million in cash and investments, and management reiterated that current capital is expected to fund operations through commercialization. Notably, Hyliion reduced its 2025 revenue guidance to $5–10 million, down from $10–15 million, as commercial sales shift to next year.

  • Revenue Mix Skewed to R&D: All revenue in Q2 and year-to-date derived from R&D services for the U.S. Navy, highlighting the pre-commercial stage of the business.
  • Expense Structure Reflects R&D Intensity: R&D spending grew to $10.1 million, accounting for nearly two-thirds of total operating expenses, as the company prioritized technical milestones.
  • Cash Position Remains a Strategic Asset: $185.3 million in liquidity provides runway to absorb delays and iterate on product-market fit ahead of broader commercialization.

Hyliion’s financial profile remains that of a development-stage company, with near-term results dictated by technical execution and partnership conversion rather than commercial scale.

Executive Commentary

"As part of the newly enacted One Big Beautiful Bill Act, a 30% investment tax credit has been established for customers deploying linear generators or fuel cells. This tax credit will apply to projects that begin construction in 2026 or later and will remain in effect for the next 10 years. This credit will apply not only to the generator itself, but also to the supporting infrastructure required for its operation. We believe this credit is significant for both Hyliion and our customers as it affirms the value that fuel-agnostic linear generators like the Carnot power module offer in addressing the growing need for clean, distributed power generation in the U.S."

Thomas Healy, Chief Executive Officer

"Our previous forecast of $10 to $15 million in revenue for 2025 included both R&D services and sales of 200 kilowatt Carnal modules to commercial customers. As Thomas mentioned earlier, we now expect the commercialization will extend into 2026. We are therefore adjusting our 2025 revenue forecast down to $5 to $10 million to account for this shift."

John Panzer, Chief Financial Officer

Strategic Positioning

1. Carno Power Module: Validation and Delayed Commercialization

Hyliion’s core product, the Carno Power Module, is positioned as a fuel-agnostic, distributed generation solution for both military and commercial markets. The company’s decision to delay commercialization until 2026 reflects a disciplined approach to product validation, emphasizing the importance of field learnings from its Early Adopter Program. This move is designed to ensure reliability, integrate customer feedback, and avoid premature scaling risks.

2. Manufacturing Control and Technical De-Risking

Transitioning linear electric motor (LEM) production in-house was a critical step to resolve persistent quality and supply issues from contract manufacturing partners. Additionally, the successful redesign and depowdering of the regen component—a 3D-printed heat exchanger core—addresses a key performance bottleneck. These milestones restore confidence in Hyliion’s ability to deliver on its technical roadmap and support future scaling.

3. Policy and Partnership Catalysts

The 30% investment tax credit under the One Big Beautiful Bill Act provides a decade-long economic tailwind for Carno deployments, making the technology more attractive for both public and private sector customers. The $1 billion non-binding MOU with Al-Qurayef Industries in Saudi Arabia and the LOI with MMR Group for initial commercial deployments in 2026 signal growing international and utility interest, although both agreements remain subject to definitive contracts.

4. Military Channel as Launchpad

Hyliion’s partnership with the U.S. Navy and new “awardable” status from the Air Force position the company to leverage defense as a validation and scaling channel. The Navy’s use of Carno units in autonomous vessels and stationary base applications, coupled with ongoing SBIR contract wins, provide both funding and credibility that could accelerate adoption in adjacent government and commercial markets.

Key Considerations

This quarter’s developments reflect a company balancing near-term technical de-risking with long-term market positioning. Investors should track Hyliion’s execution on the following:

Key Considerations:

  • Execution on Early Adopter Program: Timely delivery and field validation of all 10 early units will be critical for customer confidence and future orders.
  • Manufacturing Scalability: In-house LEM production must scale efficiently to meet 2026 demand without sacrificing quality or margin.
  • Conversion of Pipeline to Firm Orders: Non-binding MOUs and LOIs must translate into definitive contracts and meaningful backlog as commercialization approaches.
  • Cash Burn and Capital Discipline: Maintaining cash runway through commercialization is essential, especially with revenue delayed and capital spending ongoing.

Risks

Hyliion faces execution risk in scaling manufacturing and achieving reliable field performance as it transitions from R&D to commercial sales. The company’s reliance on a handful of early customers, especially the U.S. military, exposes it to concentration risk if pilots do not convert to scale. Delays in regulatory certification, supply chain disruptions, or failure to secure definitive commercial contracts could threaten the commercialization timeline and cash runway.

Forward Outlook

For Q3 2025, Hyliion guided to:

  • Continued revenue from R&D services, driven by Navy contracts and early adopter deliveries
  • Completion of UL certification for the Carno system as a key milestone

For full-year 2025, management lowered guidance:

  • Revenue now expected in the $5–10 million range, reflecting the shift of commercial sales to 2026

Management highlighted several factors that will shape the outlook:

  • Execution on technical milestones and field validation of Carno units
  • Conversion of MOUs and LOIs into firm commercial orders for 2026 and beyond

Takeaways

Hyliion’s Q2 resets the near-term narrative from commercialization to technical validation and partnership building, with a strong policy and capital base supporting the long-term vision.

  • Technical Progress: In-house LEM production and regen redesign resolve key blockers, but full system validation in customer hands remains the next hurdle.
  • Strategic Partnerships: The $1B Saudi MOU and U.S. military channel offer major upside, but execution and contract conversion are critical.
  • Investor Focus: Track cash discipline, field results from early adopter units, and the pace at which non-binding deals become revenue-generating contracts as commercialization nears.

Conclusion

Hyliion enters the second half of 2025 with technical bottlenecks behind it and a clear path to commercial launch in 2026, but faces a critical period of field validation, partnership conversion, and capital discipline. The next quarters will test the company’s ability to turn policy tailwinds and pilot wins into sustainable growth.

Industry Read-Through

Hyliion’s experience highlights the long gestation period required to bring breakthrough clean power technologies from lab to market, especially in regulated and mission-critical sectors. The 30% investment tax credit signals bipartisan policy support for distributed generation and fuel-agnostic solutions, likely benefiting peers in linear generation and advanced fuel cell markets. Military pilot programs continue to serve as a proving ground for energy innovation, offering a template for other emerging tech firms seeking validation and early scale. Investors in the distributed energy and industrial decarbonization space should watch for similar shifts from technical milestone to commercial execution as policy and partnership catalysts accelerate industry transformation.